Genesis Health Review

Genesis Health (trygenesis.com) — Provider Profile

⚠️ April 2026 — FDA Warning Letter: The FDA issued a formal warning letter to Genesis Health International Inc. (reference 721451, dated February 20, 2026) citing misleading marketing around compounded semaglutide and tirzepatide. Genesis Health was found to display compounded products with a "Genesis" label falsely implying they are the licensed compounder, and to make claims suggesting equivalence with FDA-approved medications. The FDA warning letter does not mean the company has been shut down, but it is a significant compliance red flag patients should weigh. Genesis claims to offer branded medications (Wegovy, Zepbound) in addition to compounded options — verify availability directly before enrolling.

Overview

Genesis Health is a Boynton Beach, FL-based telehealth platform offering GLP-1 weight loss medications alongside a broader wellness catalog including NAD+ therapy, hormone treatments, and ED medications. Their weight loss program focuses on compounded semaglutide and tirzepatide, with branded options (Wegovy, Ozempic, Zepbound) also listed. The company's core differentiator is flat-rate pricing — "same price at every dose" — meaning patients don't pay more as they titrate to higher maintenance doses.

April 2026 context: The compounded GLP-1 market is under active FDA enforcement pressure following FDA enforcement. Genesis Health's claims to offer branded medications (Wegovy, Zepbound) are worth investigating for patients who want ongoing access — if accurate, this distinguishes them from compounding-only platforms like Henry Meds or the now-struggling Trimi. However, the February 2026 FDA warning letter raises questions about their compliance posture and marketing transparency. Genesis Health is a small company with very limited review history (~15–22 Trustpilot reviews), making independent quality assessment difficult. Orforglipron at $149/month (available through Ro, GoodRx Care, and most major platforms) is the standard branded budget option for 2026.

Medications Offered

GLP-1 / Weight Loss:

• Compounded semaglutide — non-FDA-approved; availability uncertain given 2025-2027 enforcement
• Compounded tirzepatide — non-FDA-approved; removed from shortage list October 2024
• Branded Wegovy — FDA-approved semaglutide for weight loss
• Branded Ozempic — FDA-approved semaglutide, often prescribed off-label for weight loss
• Branded Zepbound — FDA-approved tirzepatide for weight loss

Other services: NAD+ (injection, nasal spray), Sermorelin, Glutathione, MIC+B12, Methylene Blue, hair loss (Finasteride), women's hormone therapy, ED medications.

Note: Branded medication availability is listed on their website but should be confirmed directly — the FDA warning letter specifically flagged misleading claims about Genesis's compounded vs. FDA-approved product offerings.

Pricing

Includes: consultation, medication, free expedited shipping. No price increase as dose titrates up. FSA/HSA eligible. Branded medications (Wegovy, Zepbound) are not priced at these levels — expect significantly higher costs if pursuing branded options.

States Served

Not publicly listed. Genesis's Terms and Conditions state "certain services are only available to individuals located in certain states." Contact them directly to verify coverage in your state before enrolling.

Insurance

Cash-pay only. Genesis Health does not accept commercial insurance, Medicare, or Medicaid. FSA/HSA cards accepted.

Consultation Process

Model: Async — no in-person or video visit required.

1. Complete an online health assessment (health history, current medications, BMI, weight loss goals)
2. Licensed provider reviews assessment and issues prescription (same-day possible)
3. Medication shipped directly to your home (free expedited shipping)
4. 24/7 provider messaging for ongoing dose adjustments and questions

Pros

• Flat-rate pricing — no price increase as dosage titrates ("same price at every dose")
• Broad medication catalog: both compounded and claims of branded options
• Free expedited shipping included at all plan tiers
• Bundled pricing (consultation + medication + shipping) with no hidden fees
• FSA/HSA eligible
• Multiple save-by-commitment options (quarterly, semi-annual, annual)

Cons

• FDA warning letter (Feb 2026): Cited for misleading marketing on compounded product labeling and claims of equivalence with FDA-approved drugs — serious compliance red flag
• Compounded GLP-1 supply has effectively reached zero across the industry; compounded options may be unavailable
• Very limited independent review history (~15–22 Trustpilot reviews at 4.0/5) — insufficient to assess quality or outcomes at scale
• No insurance acceptance — entirely cash-pay
• States served not publicly disclosed — availability uncertain
• No founding year or leadership team publicly identified — limited transparency
• Async-only model: no video consultations, no dietitian access, no lab work
• No coaching, behavioral support, or wraparound care included

Best For

At this time, Genesis Health is not recommended as a primary choice given the FDA warning letter, limited track record, and compounded market collapse. Patients interested in branded GLP-1s at budget pricing should verify directly whether Genesis currently offers orforglipron, Wegovy, or Zepbound — if so, compare pricing against established platforms (Ro, GoodRx Care, LifeMD) before committing.

Editorial Verdict

Genesis Health's "same price at every dose" framing is genuinely patient-friendly — titration pricing games are a real pain point on many platforms. Their broader wellness menu (NAD+, hormones, ED) could appeal to patients wanting a single telehealth relationship. But the February 2026 FDA warning letter is hard to look past. The specific violations — falsely implying Genesis is the compounder, and suggesting their compounded drugs are equivalent to FDA-approved products — point to marketing practices that prioritize conversion over patient clarity. That's the opposite of what we look for on Telehealth Ally.

Genesis's Trustpilot presence (15–22 reviews) is too thin to draw reliable conclusions. By comparison, Ro has thousands of reviews; Hims has tens of thousands. Genesis Health may be a legitimate and improving operation, but the evidence isn't there yet to confidently recommend them.

Bottom line as of April 2026: With the compounded market collapsed and an FDA warning letter on record, patients are better served by established branded-medication platforms. If Genesis Health has genuinely pivoted to branded medications with competitive pricing, we'll re-evaluate. For now, Ro (which is expected to offer orforglipron at $149/mo upon FDA approval — PDUFA April 10, 2026), GoodRx Care, and LifeMD offer more transparency and a longer track record.

Related Content

• Best GLP-1 Weight Loss Programs 2026 — All providers ranked
• FDA Enforcement Tracker for Telehealth GLP-1 Providers — Compounding crackdown tracker
• GLP-1 Pricing Breakdown by Provider — Side-by-side cost comparison
• Compounded vs Brand GLP-1 FAQ — Understanding the differences
• How to Switch GLP-1 Providers in 2026 — Provider transition guide